Nalaganje...
Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality
The hallmarks of renal cell carcinoma (RCC) are angiogenesis and immunogenic tumor microenvironment. Over the past decades, treatment options for metastatic RCC (mRCC) have been expanding, from the inhibition of vessel formation via antiangiogenic agents (AAs) to the stimulation of immune system by...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7403214/ https://ncbi.nlm.nih.gov/pubmed/32850419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01321 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|